HIBISCUS study: Exploring the use of a new drug in patients with sickle cell disease
For this year’s Black History Month, we wanted to highlight one of our research studies, HIBISCUS, which is exploring the use of a new drug, Etavopiat, in patients with sickle cell disease.
By NIHR Wellcome King's Clinical Research Facility at 31 Oct 2024